Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 01 Apr 2025

Exploring the impact of cuproptosis on prostate cancer prognosis via RNA methylation regulation based on single cell and bulk RNA sequencing data

in Pharmacology of Anti-Cancer Drugs

Junchao Wu
Wentian Wu
Jiaxuan Qin
Ziqi Chen
Rongfang Zhong
Peng Guo
Song Fan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1573611

361 views

Case Report

Published on 01 Apr 2025

Case Report: Second-line favourable effect of pembrolizumab plus chemotherapy in a patient with metastatic hepatoid adenocarcinoma of the stomach

in Pharmacology of Anti-Cancer Drugs

Yao Tang
Xiaofen Li
Yu Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1387661

260 views

Systematic Review

Accepted on 31 Mar 2025

Global trends in resistance studies of gemcitabine and pancreatic cancer: a bibliometric and visual analysis from 2010 to 2024

in Pharmacology of Anti-Cancer Drugs

Dandan Gu
Shaoyang Huang
Kai Zhao
Xiaohong Zhang
Jinjing Zhang
Wei Xiong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1564561

Review

Published on 28 Mar 2025

The multiple functions and mechanisms of long non-coding RNAs in regulating breast cancer progression

in Pharmacology of Anti-Cancer Drugs

Yongsheng Zhang
Yanjiao Xu
Yanping Zhang
Shoushi Wang
Mingqiang Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559408

332 views

Review

Published on 28 Mar 2025

Targeting the inhibitors of apoptosis proteins (IAPs) to combat drug resistance in cancers

in Pharmacology of Anti-Cancer Drugs

Qingmei Ye
Xiao-Zhao Zhuang
Juan Li
Xin Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1562167

484 views

Review

Published on 28 Mar 2025

The potential of dibenzazepine carboxamides in cancer therapy

in Pharmacology of Anti-Cancer Drugs

Nastaran Afsordeh
Safura Pournajaf
Javad Mirnajafi-Zadeh
Mohammad Hossein Pourgholami

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1564911

431 views

Original Research

Published on 28 Mar 2025

Schisandrin B downregulates exosomal fibronectin 1 expression to inhibit hepatocellular carcinoma growth

in Pharmacology of Anti-Cancer Drugs

Baoyi Jiang
Jie Yang
Qingtian Huang
Wei Li
Qian Peng
Huoye Gan
Tieli Peng
Leyi Yao
Ling Qi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1547685

401 views

Original Research

Accepted on 27 Mar 2025

Knowledge, attitudes, and practices of healthcare providers toward ADR reporting regarding thiopurine drugs for the treatment of acute lymphoblastic leukemia at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia

in Pharmacology of Anti-Cancer Drugs

Eyuel Kassa
Mastewal Birhan
Mulugeta Ayalew
Aschalew Gelaw
Abdulkader Mohamedsaid Gidey
Degalem Tilahun Worku
Hiyaw Abebe
Ermias Teklehaimanot
Nega Berhane Tessemma

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1486415

125 views

Original Research

Published on 27 Mar 2025

Enhancing survival outcomes in unresectable hepatocellular carcinoma: a prospective cohort study on the effects of Huaier granules with targeted therapy plus immunotherapy

in Pharmacology of Anti-Cancer Drugs

Hui Li
Hongliang Zhang
Wenting He

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1529010

460 views

Mini Review

Published on 27 Mar 2025

Molecular mechanisms and signaling pathways related to brain metastasis in breast cancer

in Pharmacology of Anti-Cancer Drugs

Zhuming Liang
Yanan Mo
Yujiao Zhang
Yanjing Yu
Yinan Ji

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1585668

773 views

Original Research

Published on 27 Mar 2025

The characteristics of adverse reactions of three anti-prostate cancer drugs based on Vigiaccess database and bibliometric analysis

in Pharmacology of Anti-Cancer Drugs

Jianqing Wang
Jia You
Weixing Huang
Chiting Yuan
Jiangjie Chen
Feifei Wang
Wei Wang
Liwei Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1570661

792 views

Review

Published on 27 Mar 2025

Recent advancement in the anticancer efficacy of the natural flavonoid scutellarin: a comprehensive review

in Pharmacology of Anti-Cancer Drugs

Deena Elsori
Pratibha Pandey
Meenakshi Verma
Nasir Vadia
R. Roopashree
Manish Vyas
L. Lakshmi
Laxmidhar Maharana
Deepak Nathiya
Mohd Saeed

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1579609

433 views

Case Report

Accepted on 26 Mar 2025

Excellent Efficacy of Trastuzumab Deruxtecan in a Patient with HER2-Positive Advanced Breast Cancer Complicated by Pulmonary Lymphangitic Carcinomatosis: A Case Report and Literature Review

in Pharmacology of Anti-Cancer Drugs

Simin Luo
Jie Chai
Lin Xiaoxiao Ding
Song Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1574286

131 views

Case Report

Accepted on 26 Mar 2025

Transformative Potential of Trastuzumab Deruxtecan in the First Line Treatment for Advanced HER2-Mutated Lung Adenocarcinoma: A Case Report and Clinical Insights

in Pharmacology of Anti-Cancer Drugs

Guanbin Huang
Tongtong Xia
Dongxiao Yang
Muwen Lin
Yiping Luo
Yuchan Li
Hualin Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1564834

112 views

Review

Published on 26 Mar 2025

CLDN18.2: a potential nanotherapeutic target for cholangiocarcinoma

in Pharmacology of Anti-Cancer Drugs

Yu Huang
Yulu Ye
Tingzhuang Yi
Cheng Yuan
Daojun Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559558

880 views

Perspective

Published on 26 Mar 2025

Rethinking corticosteroids use in oncology

in Pharmacology of Anti-Cancer Drugs

Pierrick Martinez
Jean-Marc Sabatier

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1551111

1,041 views